Aspirin and Cardiovascular Risk in Individuals With Elevated Lipoprotein(a): The Multi-Ethnic Study of Atherosclerosis.
Harpreet Singh BhatiaPatrick J TrainorSamantha M CarlisleMichael Y TsaiMichael H CriquiAndrew DeFilippisSotirios TsimikasPublished in: Journal of the American Heart Association (2024)
Aspirin use was associated with a significantly lower risk for CHD events in participants with lipoprotein(a) >50 mg/dL without baseline CVD. The results of this observational propensity-matched study require confirmation in studies with randomization of aspirin use.